Home › Therapeutic areas › Neurology › Autism Spectrum Disorder
Autism Spectrum Disorder (3 companies)
Companies with an active program in Autism Spectrum Disorder.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics | DermatologyMetabolic+1 Rare | 1 | Phase 3 | $25.6M | 3 |
| DFTX | Definium Therapeutics | Neurology | 1 | Phase 3 | $4.47B | 4 |
| MPLT | MapLight Therapeutics | Neurology | 1 | Phase 2 | $385M | 6 |
No companies match.